On this page
Amphetamine
Active ingredient 5 prescription 19 with labelling
Overview
Source: NDC DirectoryIngredient name
AMPHETAMINE
Base moiety
AMPHETAMINE
RxNorm CUI
UNII
CK833KGX7E
Medication products
5
Brand names
5
Dosage forms
3
FAERS reports
50,216 · not a risk measure
- Dyanavel XR amphetamine · Suspension, Extended Release
- Adzenys XR-ODT Amphetamine · Tablet, Orally Disintegrating
- Amphetamine Tablet, Orally Disintegrating
- Amphetamine Extended-Release Tablet, Orally Disintegrating
- DYANAVEL XR amphetamine · Tablet, Extended Release
Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.
By dosage form
| Dosage form | Products | Examples |
|---|---|---|
| TABLET, Orally Disintegrating | 3 | Adzenys XR-ODT, Amphetamine, Amphetamine Extended-Release |
| SUSPENSION, Extended Release | 1 | Dyanavel XR |
| TABLET, Extended Release | 1 | DYANAVEL XR |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Ingredient name, strengths, products, labelers, packages |
| DailyMed RxNorm mappings | NLM | RxNorm concept identifier (RxCUI) |
| FAERS | FDA | Adverse event report totals |